These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16902173)

  • 21. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
    Bastos-Leite AJ; van der Flier WM; van Straaten EC; Staekenborg SS; Scheltens P; Barkhof F
    Stroke; 2007 Dec; 38(12):3182-5. PubMed ID: 17962598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.
    Galluzzi S; Talassi E; Belussi M; Scheltens P; van de Pol L; Nobili F; Rodriguez G; Froelich L; Damian M; Martinez-Lage P; Gomez-Isla T; Reynish E; Ousset PJ; Vellas B; Frisoni GB
    Dement Geriatr Cogn Disord; 2008; 26(4):314-22. PubMed ID: 18841016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overtime reliability of medial temporal lobe atrophy rating in a clinical setting.
    Cavallin L; Løken K; Engedal K; Oksengård AR; Wahlund LO; Bronge L; Axelsson R
    Acta Radiol; 2012 Apr; 53(3):318-23. PubMed ID: 22371624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between right medial temporal lobe atrophy and persecutory delusions in patients with dementia of the Alzheimer's type demonstrated on VSRAD advance.
    Tagawa R; Hashimoto H; Matsuda Y; Uchida K; Yoshida A; Higashiyama S; Kawabe J; Toshihiro K; Shiomi S; Mori H; Inoue K
    Osaka City Med J; 2014 Dec; 60(2):73-80. PubMed ID: 25803882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular risk factors and the effect of white matter lesions on extrapyramidal signs in Alzheimer's disease.
    Park MH; Min JY; Kwon DY; Lee SH; Na HR; Cho ST; Na DL
    Int Psychogeriatr; 2011 Jun; 23(5):780-7. PubMed ID: 21110907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid/serum IgG index is correlated with medial temporal lobe atrophy in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2008; 25(2):144-7. PubMed ID: 18097142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients].
    Tokuchi R; Deguchi K; Yamashita T; Abe K
    Nihon Ronen Igakkai Zasshi; 2014; 51(4):342-9. PubMed ID: 25327368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.
    Lehmann M; Koedam EL; Barnes J; Bartlett JW; Ryan NS; Pijnenburg YA; Barkhof F; Wattjes MP; Scheltens P; Fox NC
    Neurobiol Aging; 2012 Mar; 33(3):627.e1-627.e12. PubMed ID: 21596458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population.
    Cavallin L; Bronge L; Zhang Y; Oksengård AR; Wahlund LO; Fratiglioni L; Axelsson R
    Acta Radiol; 2012 Jun; 53(5):573-9. PubMed ID: 22593123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
    Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
    Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease.
    Kandiah N; Chander R; Zhang A; Yee CC
    J Neurol Sci; 2014 Feb; 337(1-2):162-6. PubMed ID: 24378065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study.
    Richard E; Gouw AA; Scheltens P; van Gool WA
    Stroke; 2010 Mar; 41(3):554-6. PubMed ID: 20056923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.
    Claus JJ; Coenen M; Staekenborg SS; Schuur J; Tielkes CEM; Koster P; Scheltens P
    J Alzheimers Dis; 2018; 63(3):1129-1139. PubMed ID: 29710708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Scheltens P; Poggesi A; Weinstein HC; Scherder EJ
    Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical white matter lesions and medial temporal lobe atrophy are associated with EEG slowing in a memory clinic cohort.
    Kramberger MG; Giske K; Cavallin L; Kåreholt I; Andersson T; Winblad B; Jelic V
    Clin Neurophysiol; 2017 Sep; 128(9):1575-1582. PubMed ID: 28709123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.
    Migliaccio R; Agosta F; Possin KL; Canu E; Filippi M; Rabinovici GD; Rosen HJ; Miller BL; Gorno-Tempini ML
    J Alzheimers Dis; 2015; 46(2):351-64. PubMed ID: 25737041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe.
    den Heijer T; Launer LJ; Prins ND; van Dijk EJ; Vermeer SE; Hofman A; Koudstaal PJ; Breteler MM
    Neurology; 2005 Jan; 64(2):263-7. PubMed ID: 15668423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of automated medial temporal lobe atrophy scale to Alzheimer disease.
    Ridha BH; Barnes J; van de Pol LA; Schott JM; Boyes RG; Siddique MM; Rossor MN; Scheltens P; Fox NC
    Arch Neurol; 2007 Jun; 64(6):849-54. PubMed ID: 17562933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.